CellSource Co., Ltd.

Tokyo Stock Exchange 4880.T

CellSource Co., Ltd. Cash and Short-Term Investments for the year ending October 31, 2023: USD 31.51 M

CellSource Co., Ltd. Cash and Short-Term Investments is USD 31.51 M for the year ending October 31, 2023, a 50.10% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

CellSource Co., Ltd. Cash and Short-Term Investments for the year ending October 31, 2022 was USD 20.99 M, a -0.64% change year over year.
CellSource Co., Ltd. Cash and Short-Term Investments for the year ending October 31, 2021 was USD 21.12 M, a 25.87% change year over year.
CellSource Co., Ltd. Cash and Short-Term Investments for the year ending October 31, 2020 was USD 16.78 M, a 35.91% change year over year.
CellSource Co., Ltd. Cash and Short-Term Investments for the year ending October 31, 2019 was USD 12.35 M, a 451.53% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Tokyo Stock Exchange: 4880.T

CellSource Co., Ltd.

CEO	Mr. Takashi Sawada
IPO Date	Oct. 29, 2019
Location	Japan
Headquarters	Shibuya Mitake Building
Employees	151
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years